ZUG, Switzerland, April 23, 2026--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. Strong ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...

HONG KONG (AP) — Stocks retreated in Asia on Thursday after an initial jump that pushed Japan's Nikkei 225 index above 60,000 for the first time, while oil prices gained as investors reacted to shaky ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SEOUL, April 23 (Reuters) - South Korea's data protection agency said on Thursday it has fined a matchmaking service ‌over the leak of its members' sensitive personal information, including their ...

EOG Resources (EOG) is back in focus as it prepares to report first quarter results, with analysts watching whether a modestly higher earnings outlook and its recent pattern of earnings beats continue ...

Digimarc Corporation (NASDAQ: DMRC), a leading provider in digital identity and authentication solutions, will hold a conference call on Tuesday, May 12, 2026, at 5 p.m. Eastern time (2 p.m. Pacific ...

Iran seized two container ships seeking to exit the Gulf via the strait on Wednesday, tightening its grip on the waterway ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced the pricing of its previously announced ...